BRIEF published on 03/19/2025 at 07:35, 1 month 11 days ago Nicox a terminé la dernière visite de l'essai de phase 3b NCX 470 sur le glaucome à Whistler Nicox Résultats Cliniques NCX 470 Glaucome Essai De Phase 3b
BRIEF published on 03/19/2025 at 07:35, 1 month 11 days ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 1 month 11 days ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
PRESS RELEASE published on 03/19/2025 at 07:30, 1 month 11 days ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF published on 01/28/2025 at 07:35, 3 months 2 days ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 3 months 2 days ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 3 months 2 days ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 3 months 2 days ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 3 months 8 days ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
BRIEF published on 01/22/2025 at 07:35, 3 months 8 days ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
Published on 04/30/2025 at 08:00, 47 minutes ago Argo Blockchain PLC Announces Financial Update and Listing Suspension Request
Published on 04/30/2025 at 01:25, 7 hours 22 minutes ago UniDoc Provides Update on Marketing Engagement
Published on 04/30/2025 at 01:20, 7 hours 27 minutes ago Electric Metals (USA) Limited Closes $3.0 Million Non-Brokered Private Placement Led by Eric Sprott and Crescat Capital
Published on 04/29/2025 at 23:30, 9 hours 17 minutes ago Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants
Published on 04/30/2025 at 08:30, 17 minutes ago Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.
Published on 04/30/2025 at 08:12, 35 minutes ago Thalassa Holdings Ltd: Annual Report and Audited Accounts to 31 December 2024
Published on 04/30/2025 at 08:00, 47 minutes ago Dalata Announces First Hotel in Spain and Third in Continental Europe
Published on 04/30/2025 at 08:30, 17 minutes ago Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:02, 13 hours 44 minutes ago LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 14 hours 25 minutes ago BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 14 hours 35 minutes ago 250429 BENETEAU Avis de mise à disposition de documents
